Combined Studies of Complement Receptor and Surface Immunoglobulin-Bearing Cells and Sheep Erythrocyte Rosette-Forming Cells in Normal and Leukemic Human Lymphocytes

Journal of Clinical Investigation - United States
doi 10.1172/jci107194
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Immunoglobulin and Complement Receptor-Bearing Cells in Cultures of Mouse Decidual Tissue

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
1981English

Electron Microscope Study of Surface Immunoglobulin-Bearing Human Tonsil Cells

Journal of Experimental Medicine
MedicineAllergyImmunology
1972English

Protein Concentration in Normal Mouse Lymphocytes, Thymocytes, and Mouse and Human Leukemic Cells as Measured by Interference Microscopy

Journal of General Physiology
Physiology
1959English

Effect of Combined Arginase and Nitric Oxide Donor Treatment on Normal and Leukemic Cells in Vitro

Studia Biologica
2016English

Antigen Recognition by T-Cells and Its Suppression. Significance and Origin of Rosette-Forming Cells.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1971English

Variation in Accessible Cell Surface Immunoglobulin Among Antibody-Forming Cells

Journal of Experimental Medicine
MedicineAllergyImmunology
1972English

Separation of Concanavalin A-Induced Human Suppressor and Helper T Cells by the Autologous Erythrocyte Rosette Technique.

Journal of Clinical Investigation
Medicine
1981English

Ultrastructural Study of Spontaneous Bone Marrow Rosette-Forming Cells

Journal of Cell Biology
MedicineCell Biology
1977English

Monoglycerides Induce Apoptosis in Human Leukemic Cells While Sparing Normal Peripheral Blood Mononuclear Cells

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy